TILT Biotherapeutics was highlighted as one of the key companies developing oncolytic viruses in an interesting report entiteled ” A New Wave of Cancer Therapies: Local Tumor Immuno-Rx Drives Distant Effects”, published by Piper Jaffray & Co.
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events:
11-13th December 2024
ESMO Immuno-Oncology Congress
Geneva, Switzerland
13-15th January 2025
Biotech Showcase
San Francisco (CA), USA